(Q39073648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Michaela B. Kirschner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Nico van Zandwijk

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Casey M Wright

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

M E Pel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Y Y Cheng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

N Mugridge

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J Weiss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M Williams

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J J B Edelman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M P Vallely

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

B C McCaughan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

S Klebe

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

H Brahmbhatt

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J A MacDiarmid

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

22 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

3128-3135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24148817%20AND%20SRC:MED&resulttype=core&format=json

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Chemotherapy and targeted therapies for unresectable malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

MicroRNAs dysregulation in human malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Pro-tumorigenic effects of miR-31 loss in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Validation of tissue microarray technology in malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412

miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT412